Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q3 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
CVS:US | CVS Health Corporation | Common share | - | US1266501006 | $53.19 |
Company name | CVS Health |
---|---|
Tags | #s&p500 index |
Sector | Consumer Staples / Food & Staples Retailing / Food & Staples Retailing / Drug Retail |
Business address | ONE CVS DR. WOONSOCKET RI 02895 4017651500 |
Mailing address | ONE CVS DR. WOONSOCKET RI 02895 |
Website | investors.cvshealth.com |
Information disclosure | www.sec.gov |